Web Results

Merck & Co., Inc. v. Reynolds : SCOTUSblog

www.scotusblog.com/case-files/cases/merck-co-inc-v-richard-reynolds-2/

Apr 27, 2010 ... Merck & Co., Inc. v. ... Joint Appendix Volume I · Brief for Respondent Richard Reynolds, et al. Reply Brief for Petitioner Merck & Co. ... Brief for Dr. Harlan M. Krumholz and Dr. Joseph S. Ross in Support of Respondents ...

Merck Drug Patents Asserted Against Gilead Valid, Jury Finds ...

www.law360.com/articles/775066/merck-drug-patents-asserted-against-gilead-valid-jury-finds

Mar 22, 2016 ... The case is Gilead Sciences Inc. v. Merck & Co. Inc. et al., case number 5:13-cv- 04057, in the U.S. District Court for the Northern District of ...

Merck To Pay Up To $10M To Settle Coppertone False Ad Suit ...

www.law360.com/articles/380739/merck-to-pay-up-to-10m-to-settle-coppertone-false-ad-suit

Sep 24, 2012 ... The suit is Steven Brody et al. v. Merck & Co. Inc. et al., case number 3:12-cv- 04774, filed in U.S. District Court for the District of New Jersey.

What have we learnt from Vioxx? - NCBI - National Institutes of Health

www.ncbi.nlm.nih.gov/pmc/articles/PMC1779871/

Jan 20, 2007 ... Harlan M Krumholz, Harold H Hines Junior professor of medicine and ... Rofecoxib (Vioxx) was introduced by Merck in 1999 as an effective, safer ..... Letter re: financial disclosure for Merck and Co, Inc sponsored protocol entitled: ... Deborah Shapiro, et al. re: fw: for review [peer]: 2001-ms-2470 (full paper) .....

Pooled Analysis of Rofecoxib Placebo-Controlled Clinical ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC2830805/

Nov 23, 2009 ... Merck, the maker of rofecoxib, promoted it as a safer alternative to .... plaintiffs and against Merck and Co., Inc. While the authors obtained access to the .... Our analysis builds upon the prior work of Jüni et al., published shortly .... Cona v. Merck and Co., Inc.] 2000. Mar 9 [Last Accessed December 1, 2008].

Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data ...

archinte.jamanetwork.com/article.aspx?articleid=1108579

Nov 23, 2009 ... ... MHS; David S. Egilman, MD, MPH; Yongfei Wang, MS; Harlan M. Krumholz, MD, SM ... Merck & Co Inc, Whitehouse Station, New Jersey (hereinafter, ..... Our analysis builds on the prior work of Jüni et al, published shortly after .... of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis.

Kirkland & Ellis LLP > Lefkowitz, P.C., Jay P.

www.kirkland.com/lefkowitz

Harlan Fiske Stone Scholar (1985-86) ... West-Ward Pharmaceuticals, Inc. et al.; Yamane v. .... 180 days of marketing exclusivity for its generic version of Merck's blockbuster drug Zocor following Merck's request to remove the patents claiming  ...

Home Use of a Bihormonal Bionic Pancreas Improves Glycemic ...

www.endocrineweb.com/professional/meetings/home-use-bihormonal-bionic-pancreas-improves-glycemic-control-reduces-hypoglyc

Jun 20, 2016 ... They evaluated a bihormonal pump vs conventional insulin pump therapy in adults .... Elkhatib F, Buckingham BA, Buse JB, Harlan DM, et al. ... Therapeutics, Inc., GI Dynamics, Inc., Lexicon Pharmaceuticals, Inc., Merck & Co., ...

Monday, November 30 | Public Education - American Bar Association

www.americanbar.org/publications/preview_home/publiced_preview_briefs_dec09.html

Brief for Petitioner Graham County Soil & Water Conservation District, et al. ... Merck & Co., Inc.,v. ... for Dr. Harlan M. Krumholz and Dr. Joseph S. Ross in Support of Respondents ... Brief for Petitioner Milavetz, Gallop & Milavetz, P.A., et al.

Preamble Preemption and the Challenged Role of Failure to Warn ...

scholarlycommons.law.hofstra.edu/cgi/viewcontent.cgi?article=2287&context=hlr

Gregory D. Curfman et al., Editorial, Blueprint for a Stronger Food and Drug. Administration ... Whether, under the conflict preemption principles in Buckman Co. v. Plaintiffs' ..... Merck & Co., Inc., Annual Report (Form. 10-K), at 5, ..... See Harlan M. Krumholz et al., What Have We Learnt From Vioxx?, 334 BRITISH MED . J.

More Info

GILEAD SCIENCES, INC. v. MERCK & CO, INC. by BETH LABSON ...

www.leagle.com

Feb 25, 2016 ... Merck & Co, Inc., Defendant, represented by Bruce R Genderson, ... et al, Stephen Solomon Rabinowitz, Hughes Hubbard & Reed LLP, David ...

Merck Sued For Securities Fraud Over Cholesterol Drug Trial ...

www.law360.com

Dec 4, 2013 ... Merck Sued For Securities Fraud Over Cholesterol Drug Trial ... ET) -- North Sound Capital LLC and two other institutional funds have sued Merck & Co. ... The case is North Sound Capital LLC et al. v. Merck & Co. Inc. et al., case number 3:13-cv-07240, in the U.S. District Court for the District of New Jersey.

The ADVANTAGE Seeding Trial: A Review of Internal Documents ...

annals.org

Aug 19, 2008 ... During Cona v Merck and Co., Inc., and McDarby v Merck and Co., Inc., ..... Johansson G, Shoemaker JR, Schechtman J, Skalky CS, et al. ..... MD, MHS; Joseph S. Ross, MD, MHS; David S. Egilman, MD, MPH; and Harlan M.